High prevalence of infection with hepatitis C virus in patients with hepatic and extrahepatic malignancies

Abstract Background/Aims: The pathogenic role of hepatitis G virus, the recently discovered blood-borne agent, is controversial. Our aim was to ascertain the prevalence of hepatitis G virus infection in hepatic and in extrahepatic malignancies. Methods: We studied 166 Italian patients (112 male, 54 female, mean age 61.8±9.3, mean±SD, range 34–85). One hundred and eighteen had cirrhosis, which was complicated by hepatocellular carcinoma in 66 cases. Forty-eight patients had extra-hepatic malignancies. Circulating HGV RNA was detected by reverse transcriptase-polymerase chain reaction (RT-PCR) of both the nonstructural-3 and 5′ noncoding regions of the hepatitis G virus genome. Antibodies to the E2 protein of hepatitis G virus were detected by means of an enzyme-linked immunosorbent assay. Results: Ongoing HGV infection was detected in 3066 (46%) patients with hepatocellular carcinoma, 1252 (23%) patients with cirrhosis, and 1448 (29%) patients with extrahepatic malignancies ( p p Conclusions: Ongoing hepatitis G virus infection is detected at a very high rate in patients with hepatocellular carcinoma, but is also fairly common in extrahepatic malignancies. Hepatitis G virus infection in these patients is likely to originate from exposure to blood products, and to persist because of deficient immune surveillance.